Contact: Mark Bennett
203-812-2160
GCI Group

Nexavar(r) (sorafenib) tablets

Caption: Nexavar(r) (sorafenib) tablets

Credit: None

Usage Restrictions: None

Related news release: Bayer and Onyx announce pivotal Nexavar kidney cancer study published in NEJM